Arkolith/Insider Trading/OCUP/Form 4

Hoffmann Bernhard

VP of Corp. Dev. & Ops & Sec.Ocuphire Pharma, Inc. (OCUP) · full profile →Form 4 · filed Feb 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 28, 2022Grant(A)43K—$043K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-003497) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML